Skip to main content

UBC Children's and Women's Research Ethics Board

The University of British Columbia / Children’s and Women’s Health Centre of British Columbia Research Ethics Board (UBC C&W REB) is a UBC-affiliated Research Ethics Board (REB) for the Oak Street campus.

The UBC C&W REB is responsible for the ethical review of the following:

  • Clinical and behavioural research projects conducted at:
    • BC Children's Hospital and Sunny Hill Health Centre*
    • BC Mental Health & Addiction Services*
    • BC Women's Hospital & Health Centre*
    • BC Children's Hospital Research Institute
    • BC Mental Health & Addictions Research Institute
    • Women's Health Research Institute
  • Studies for which the principal investigator holds appointments with the Children’s & Women’s Health Centre of British Columbia, which directly involve patients, records or resources of the Oak Street campus. This also includes research projects which involve the use of human remains, cadavers, tissue, biological fluids, embryos and/or fetuses.

*Programs of the Provincial Health Services Authority

Site-specific requirements

  • Your research may have privacy implications - if you have questions about privacy considerations for your research study please visit the Research Privacy web pages before submitting to the REB.  
  • Researchers must obtain institutional approval from C&W prior to commencing any human subject research studies taking place at C&W which use patient or other client populations, access medical or other records, or impact C&W clinical or other service resources in any way. See our Institutional Approvals page for more details.
  • Researchers who do not hold a Children's & Women's appointment must appoint an individual who holds a Children's & Women's appointment as site lead or co-investigator for the research.

To enable researchers to secure funding from the US Department of Health and Human Services (DHHS), the UBC C&W REB and the Children's & Women's Health Centre of British Columbia have obtained OHRP Federal-wide Assurance (FWA) and Institutional Review Board (IRB) Assurance.

  • Assurance: Federal-wide Assurance (FWA)
    • Number: FWA00020398
    • Expiry date: March 13, 2023
  • Assurance: Children's and Women's Hospital IRB#1
    • Number: IRB00006995
    • Expiry date: March 11, 2024
Every institution engaged in human subjects research supported or conducted by the US DHHS is required, under the DHHS human subjects protection regulations (45 CFR 46.103), to have an assurance of compliance approved by the US Office for Human Research Protections (OHRP).

See also the C&W assurance of compliance.

OHRP has launched a webpage with information on the revised Common Rule’s clinical trial informed consent form posting requirement (45 CFR 46.116(h)). Please send questions or comments about the revised posting requirement to OHRP@hhs.gov.
The UBC C&W REB meets on the 4th Wednesday of each month, with the exception of the December meeting, which will take place on the 2nd Wednesday of the month.

The deadlines for full board review are listed below. Please note that there is no deadline for Minimal Risk studies.

Submissions must be received by 4:30 p.m. on the due date. Researchers are required to have their completed ethics application - including departmental approval - submitted to the UBC C&W REB prior to the submission deadline. Any submissions received after this time will be reviewed at the following month's meeting.

It is the Principal Investigator's responsibility to ensure that their department head has been notified of the application and ensure that departmental approval has been received prior to the deadline for submission. Departmental approval occurs electronically following Principal Investigator sign off on the application.

2020 Deadlines2020 Meetings
November 11
November 25

December 2                                            December 16 


2021 Deadlines2021 Meetings
January 13
January 27
February 10
February 24
March 10
March 31
April 14
April 28
May 12
May 26
June 9
June 23
July 7
July 28
August 4
August 25
September 1
September 22
October 6
October 27
November 3
November 24
December 1
December 15

 
A fee for ethical review only applies only to research studies sponsored by industry (i.e., pharmaceutical, biological or medical device company) or any other for profit organization.

An initial application fee of $3,500 CAD* per application covers the cost of the submission and initial review of the application. In addition, an annual renewal fee of $750 CAD* will be levied (at the time of the annual renewal) to cover the cost of the annual renewal and other on-going oversight, including amendments and unanticipated events. The Principal Investigator must ensure the sponsor is aware of these fees. 

The UBC C&W REB Office will issue an invoice once your research project has been submitted on RISe. The Certificate of Approval will not be released until the review fee has been received. If you have outstanding fees, no new REB reviews will be undertaken until your account is brought into good standing.

If your study requires a Clinical Trial Agreement or Contract, a fully executed copy of the Clinical Trial Agreement or Contract must be on file with UBC’s University-Industry Liaison Office (UILO).  They will notify the REB when the agreement has been executed and ethical approval can then be released.

For a current statement of your fee account or other specific queries relating to REB fee payment, please contact:

Talysa Dhahan 
Administrative Coordinator, UBC C&W Research Ethics Board
tdhahan@bcchr.ubc.ca  | 604-875-3103 

*Note that these fee amounts apply to all new applications submitted after April 1, 2019.  All privately sponsored studies submitted prior to April 1st, 2019 will continue to be charged the current ethical review fees of $3,000 for initial approval and $500.00 for annual renewals.

Mechanism for submitting the fee

Internal transfer from a C&W or PHSA account

Please return a copy of the invoice with the C&W or PHSA cost centre information as indicated and signatures from the appropriate authorizing signatory to the REB office.

Cheque

  • Payable to: Provincial Health Services Authority
  • Amount: $3,000.00 CAD (for initial review) or $500.00 CAD (for annual renewal)
  • Reference: REB number (HXX-XXXXX), UBC C&W Research Ethics Board, Attention: Talysa Dhahan
  • Mail to: Room A2-141A, 950 West 28th Avenue, Vancouver, BC V5Z 4H4, Canada
Attach a copy of the invoice and include the REB number (HXX-XXXXX) as a reference.


L-R: Farin Meralli, Jennie Prasad & Talysa Dhahan

Jennie Prasad, REB Manager

Jennie oversees the functioning of the REB staff and Board, monitors ethical review process standards, and advises on compliance with ethics policies. 

Ph: 604-875-2441; Email: jprasad@bcchr.ubc.ca

Farin Meralli, Research Ethics & Regulatory Specialist

Farin is responsible for the review of new full-board and minimal risk applications and associated deferral/proviso responses and general inquiries. 

Ph: 604-875-2000 ext.5396; Email: fmeralli@bcchr.ubc.ca

Talysa Dhahan, Administrative Coordinator  

Talysa is responsible for handling incoming general inquiries, post-approval activities, institutional approvals, and fee payment.

Ph: 604-875-3103; Email: tdhahan@bcchr.ubc.ca
 

Mailing address & general contact information

UBC Children's & Women’s Research Ethics Board
Room A2-141A
950 West 28th Avenue
Vancouver, BC V5Z 4H4
CANADA

Phone: 604-875-3103
Fax: 604-875-2496 


SOURCE: UBC Children's and Women's Research Ethics Board ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © Provincial Health Services Authority. All Rights Reserved.

    Copyright © 2021 Provincial Health Services Authority